ISM5411, A NOVEL GUT-RESTRICTED PHD1/2 INHIBITOR FOR INFLAMMATORY BOWEL DISEASE: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FIRST-IN-HUMAN PHASE I STUDY TO EVALUATE SAFETY, TOLERABILITY AND PK PROFILES

Gastroenterology 2026

View at publisher

Authors: Hanyang Li, Carol Satler, Heng Zhao, Yunxuan Jiang, Yuan Lv, Sujata Rao, Feng Ren, Alex Zhavoronkov

DOI: 10.1053/j.gastro.2025.10.259

Cited by: 1

Fields of Study & Subjects

Spondyloarthritis Studies and Treatments Complement system in diseases Multiple Sclerosis Research Studies